Latest filing published 24 Jun 2026 for Centessa Pharmaceuticals plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Karen M. Anderson across 2 companies, led by Centessa Pharmaceuticals plc and Mimecast Ltd. In total, 28 filings cover trades dated from 9 June 2021 to 24 June 2026.
The open-market record consists of 4 sales worth €833k, with no purchase. The rest of the record consists of 5 share grants and 17 option exercises.
The record was last updated on 24 June 2026 with a transaction in Centessa Pharmaceuticals plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations